Lucerno Dynamics

Lucerno Dynamics is a private, commercial-stage company addressing a significant quality gap in nuclear medicine administration. Founded in 2015 and based in Raleigh, North Carolina, the company has developed the Lara System, a monitoring technology designed to detect and quantify radiopharmaceutical extravasations in seconds. By providing previously unavailable data on injection quality, Lucerno aims to improve patient dosimetry, enhance diagnostic scan quality, and support the safe growth of theranostics. The company is led by a board with deep experience in healthcare, medical devices, and insurance.

The Lara® System: a monitoring technology designed to detect and quantify radiopharmaceutical extravasations (injection errors) in real-time during nuclear medicine procedures, providing data for quality control and patient-specific dosimetry.

Lucerno appears to be a first-mover in dedicated, real-time extravasation monitoring for nuclear medicine. Indirect competitors include traditional QC methods (visual inspection, site imaging) which lack quantitative data, and potentially future offerings from large imaging OEMs (GE, Siemens, Philips) or dosimetry software companies that could integrate similar functionality.